Back to ROIV

Affinity Asset Advisors, LLC → ROIV

Affinity Asset Advisors, LLC ROIV Position History

Roivant Sciences Ltd. • Healthcare

Quarters held
4
Latest value
$117M
Q3 2026
Peak value
$132.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$36.9M
Q1 2026$77.6M
Q2 2026$132.7M
Q3 2026$117M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$117M3.20M——
Q2 2026$132.7M3.75M——
Q1 2026$77.6M2.80M——
Q4 2025$36.9M1.70M——

Other funds holding ROIV

Other Affinity Asset Advisors, LLC positions

APGE

APOGEE THERAPEUTICS INC

$131M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M
EQR

ERASCA INC

$96.2M
APGE

APOGEE THERAPEUTICS INC

$93.2M